<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0121103</journal-id>
<journal-id journal-id-type="pubmed-jr-id">280</journal-id>
<journal-id journal-id-type="nlm-ta">Adv Exp Med Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Adv. Exp. Med. Biol.</journal-id>
<journal-title-group>
<journal-title>Advances in experimental medicine and biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0065-2598</issn>
<issn pub-type="epub">2214-8019</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31583588</article-id>
<article-id pub-id-type="pmc">7188602</article-id>
<article-id pub-id-type="doi">10.1007/978-981-13-9913-8_7</article-id>
<article-id pub-id-type="manuscript">NIHMS1581153</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>General Pathophysiology of Astroglia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Verkhratsky</surname>
<given-names>Alexei</given-names>
</name>
<aff id="A1">Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PT, UK</aff>
<aff id="A2">Center for Basic and Translational Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark</aff>
<aff id="A3">Achucarro Center for Neuroscience, IKERBASQUE, Basque Foundation for Science, 48011, Bilbao, Spain</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ho</surname>
<given-names>Margaret S.</given-names>
</name>
<aff id="A4">School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vardjan</surname>
<given-names>Nina</given-names>
</name>
<aff id="A5">Laboratory of Neuroendocrinology-Molecular Cell Physiology, Faculty of Medicine, Institute of Pathophysiology, University of Ljubljana, Ljubljana, Slovenia</aff>
<aff id="A6">Celica BIOMEDICAL, Ljubljana, Slovenia</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zorec</surname>
<given-names>Robert</given-names>
</name>
<aff id="A7">Laboratory of Neuroendocrinology-Molecular Cell Physiology, Faculty of Medicine, Institute of Pathophysiology, University of Ljubljana, Ljubljana, Slovenia</aff>
<aff id="A8">Celica BIOMEDICAL, Ljubljana, Slovenia</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parpura</surname>
<given-names>Vladimir</given-names>
</name>
<aff id="A9">Department of Neurobiology, The University of Alabama at Birmingham, Birmingham, AL, USA</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1">A. Verkhratsky, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PT, UK, <email>Alexej.Verkhratsky@manchester.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>2</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>29</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>1175</volume>
<fpage>149</fpage>
<lpage>179</lpage>
<!--elocation-id from pubmed: 10.1007/978-981-13-9913-8_7-->
<abstract id="ABS1">
<p id="P1">Astroglial cells are involved in most if not in all pathologies of the brain. These cells can change the morpho-functional properties in response to pathology or innate changes of these cells can lead to pathologies. Overall pathological changes in astroglia are complex and diverse and often vary with different disease stages. We classify astrogliopathologies into reactive astrogliosis, astrodegeneration with astroglial atrophy and loss of function, and pathological remodelling of astrocytes. Such changes can occur in neurological, neurodevelopmental, metabolic and psychiatric disorders as well as in infection and toxic insults. Mutation in astrocyte-specific genes leads to specific pathologies, such as Alexander disease, which is a leukodys-trophy. We discuss changes in astroglia in the pathological context and identify some molecular entities underlying pathology. These entities within astroglia may repent targets for novel therapeutic intervention in the management of brain pathologies.</p>
</abstract>
<kwd-group>
<kwd>Astrocyte</kwd>
<kwd>Neuropathology</kwd>
<kwd>Alexander disease</kwd>
<kwd>Stroke</kwd>
<kwd>Psychiatric diseases</kwd>
<kwd>Metabolic diseases</kwd>
<kwd>Neurotrauma</kwd>
<kwd>Infectious diseases</kwd>
<kwd>Systemic Inflammation</kwd>
<kwd>Sepsis-associated encephalopathy</kwd>
<kwd>Toxic encephalopathy</kwd>
<kwd>Hepatic encephalopathy</kwd>
<kwd>Autistic spectrum disorders</kwd>
<kwd>Epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>